SAN DIEGO, Sept. 9, 2021 /PRNewswire/ — Regulus Therapeutics Inc.
(Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today announced that Jay Hagan,…
Why Bitcoin may be safe but apps are not
April 15, 2026
